Comparison of amyloid plaque contrast generated by T2‐weighted, T‐weighted, and susceptibility‐weighted imaging methods in transgenic mouse models of Alzheimer's disease
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
One of the hallmark pathologies of Alzheimer's disease (AD) is amyloid plaque deposition. Plaques appear hypointense on T2‐weighted and T‐weighted MR images probably due to the presence of endogenous iron, but no quantitative comparison of various imaging techniques has been reported. We estimated the T1, T2, T, and proton density values of cortical plaques and normal cortical tissue and analyzed the plaque contrast generated by a collection of T2‐weighted, T‐weighted, and susceptibility‐weighted imaging (SWI) methods in ex vivo transgenic mouse specimens. The proton density and T1 values were similar for both cortical plaques and normal cortical tissue. The T2 and T values were similar in cortical plaques, which indicates that the iron content of cortical plaques may not be as large as previously thought. Ex vivo plaque contrast was increased compared to a previously reported spin‐echo sequence by summing multiple echoes and by performing SWI; however, gradient echo and SWI were found to be impractical for in vivo imaging due to susceptibility interface–related signal loss in the cortex. Magn Reson Med, 2009. © 2009 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Susceptibility weighted imaging (SWI)
Haacke, E. M., Xu, Y., Cheng, Y. N., & Reichenbach, J. R. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20198 · Cited by 1,582
In Vivo Magnetic Resonance Microimaging of Individual Amyloid Plaques in Alzheimer's Transgenic Mice
Jack, C. R., Wengenack, T. M., Reyes, D. A., Garwood, M., Curran, G. L., Borowski, B. J., Lin, J., Preboske, G. M., Holasek, S. S., Adriany, G., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2588-05.2005 · Cited by 148
Self-citation
Cited by
Gong, N.-J., Dibb, R., Bulk, M., van der Weerd, L., & Liu, C. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.02.019 · Cited by 162
“The non-invasive detectability of beta amyloid plaques on MR images has so far been largely attributed to focal iron deposition accompanying the plaques (Borthakur et al., 2006; Chamberlain et al., 2009; Dhenain et al., 2002b; El Tannir El Tayara et al., 2006; El Tayara Nel et al., 2007; Falangola et al., 2005; Jack e…”
Yang, J., Zaim Wadghiri, Y., Minh Hoang, D., Tsui, W., Sun, Y., Chung, E., Li, Y., Wang, A., de Leon, M., & Wisniewski, T. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.01.023 · Cited by 135
“In addition, other and our previous studies have shown that T2* values correlate with amyloid plaque burden (Chamberlain et al., 2009; Scholtzova et al., 2008).”
ResultA review of β-amyloid neuroimaging in Alzheimer's disease
Adlard, P. A., Tran, B. A., Finkelstein, D. I., Desmond, P. M., Johnston, L. A., Bush, A. I., & Egan, G. F. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00327 · Cited by 93
“…dense hydrophobic core of amyloid deposits (Lee et al., 2004; Wengenack et al., 2011), though the fact that the proton density in plaques is only slightly reduced compared to normal cortical tissue does not lend this support to this proposition (Chamberlain et al., 2009; Wengenack et al., 2011).”
BackgroundResultInfluentialKlohs, J., Politano, I. W., Deistung, A., Grandjean, J., Drewek, A., Dominietto, M., Keist, R., Schweser, F., Reichenbach, J. R., Nitsch, R. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066097 · Cited by 42
Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain
Wengenack, T. M., Reyes, D. A., Curran, G. L., Borowski, B. J., Lin, J., Preboske, G. M., Holasek, S. S., Gilles, E. J., Chamberlain, R., Marjanska, M., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.08.033 · Cited by 41
“However, proton density measurements indicated that there was no difference in water content between plaques and surrounding tissue (Chamberlain et al., 2009).”
BackgroundResultSelf-citationDudeffant, C., Vandesquille, M., Herbert, K., Garin, C. M., Alves, S., Blanchard, V., Comoy, E. E., Petit, F., & Dhenain, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-05285-1 · Cited by 34
Magnetic Resonance Imaging of Amyloid Plaques in Transgenic Mouse Models of Alzheimers Disease
Chamberlain, R., M. Wengenack, T., F. Poduslo, J., Garwood, M., & R. Jack, C. (2011) · Current Medical Imaging Reviews · doi:10.2174/157340511794653522 · Cited by 26
“Our group used ex vivo imaging to compare the plaque contrast generated by a variety of pulse sequences in order to determine which sequences provide greater plaque visibility [13].”
BackgroundMethodInfluentialSelf-citationUnveiling Molecular Events in the Brain by Noninvasive Imaging
Klohs, J., & Rudin, M. (2011) · The Neuroscientist · doi:10.1177/1073858410383433 · Cited by 22
Santin, M. D., Vandenberghe, M. E., Herard, A.-S., Pradier, L., Cohen, C., Debeir, T., Delzescaux, T., Rooney, T., & Dhenain, M. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00055 · Cited by 20
Mouse models of neurodegenerative disease: preclinical imaging and neurovascular component
Albanese, S., Greco, A., Auletta, L., & Mancini, M. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-017-9770-3 · Cited by 16
Metadata
- Authors
- Chamberlain, R., Reyes, D., Curran, G. L., Marjanska, M., Wengenack, T. M., Poduslo, J. F., Garwood, M., & Jack, C. R.
- Venue
- Magnetic Resonance in Medicine
- Publisher
- Wiley
- Published
- 2009-02-27
- Volume
- 61
- Issue
- 5
- Pages
- 1158-1164
- ISSN
- 0740-3194 (ISSN-L)
- 1522-2594
- OpenAlex
- W1967699702
- Cited by
- 62
- References
- 3
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.